New PET Tracers for Symptomatic Myeloma.

Multiple myeloma (MM) is a hematologic malignancy characterized by the clonal proliferation of plasma cells within the bone marrow. Accurate staging and monitoring of disease progression are crucial for effective management. PET imaging has emerged as a powerful tool in the diagnosis and management of MM, with radiotracers like 18F-fluorodeoxyglucose and novel agents playing a pivotal role.

Role of 18 F-FDG PET/CT for providing a targeted approach for etiology of PUO.

Aim: This study aimed to evaluate the potential role of 18F-fluorodeoxyglucose PET/computed tomography (18F-FDG PET/CT) in providing a targeted approach for diagnosing the etiology of Pyrexia of Unknown Origin (PUO).

Methods: A total of 573 PUO patients were included in this ambispective study, with a mean age of 39.40 ± 4.